131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)

NCT05450744 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplastic Disease
Glioblastoma
Glioblastoma Multiforme

Interventions

DRUG: 131I-IPA

Sponsor

Telix Pharmaceuticals (Innovations) Pty Limited